Menu

A Blood-based Biomarker for Suicide?

Epigenetic and genetic changes in the SKA2 gene are correlated with suicidal behaviors, researchers show.

Jul 31, 2014
Jyoti Madhusoodanan

FLICKR, US NAVYA blood test that reveals epigenetic and gene-expression changes in one gene, SKA2, could help identify individuals at risk of suicide or suicidal behaviors, according to a study published yesterday (July 30) in The American Journal of Psychiatry.

Led by Zachary Kaminsky of the Johns Hopkins University School of Medicine in Baltimore, Maryland, the study began with a genome-wide scan for methylation changes in neurons and glial cells in post-mortem brains to identify genes associated with suicide. The search linked epigenetic and genetic changes in a single nucleotide polymorphism (SNP), rs7208505, within the SKA2 gene to a higher probability of suicidal ideation. SKA2 gene expression was significantly lower in suicide decedents, an effect linked to variations in this SNP.

Changes in SKA2 expression were also linked to suicidal behaviors in blood tests on three live cohorts. An assessment of stress—as measured by salivary cortisol levels—suggested that the gene may act to suppress cortisol and mediate stress responses. The correlation of SKA2 with anxiety and stress could potentially “explain about 80 percent of suicidal behavior, and progression from suicidal ideation to suicide attempts,” the authors wrote in their paper.

SKA2 has been implicated as important for the normal function of stress receptors,” Kaminsky told Popular Science. “It chaperones them, and it goes up when glucocorticoid binds to these receptors, which happens when you get stressed out.”

Previous searches for blood biomarkers of suicidal thoughts have yielded other potential genes. The Scientist reported last year that researchers had identified six candidate biomarkers for suicidal thoughts, in genes related to stress and cell death. Although a simple blood test to predict an individual’s potential for suicidal thoughts could benefit the community, biomarkers for self-harm have yet to reach clinical trials. 

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Application of TruBIOME™ to Increase Mouse Model Reproducibility
Application of TruBIOME™ to Increase Mouse Model Reproducibility
With this application note from Taconic, learn about the effects of the microbiome on reproducibility and predictability and how TruBIOME™ helps researchers generate custom microbiota mouse models!
Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.